COHERUS ONCOLOGY INC (CHRS) Stock Cash Flow
NASDAQ:CHRS - US19249H1032 - Common Stock
1.35 USD
0 (-0.37%)
1.35 USD
0 (0%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 179.75M | 28.51M | N/A | -291.80M | -287.10M | |||
| Depreciation Amortization | 4.64M | 5.28M | 3.79M | 3.70M | 3.50M | |||
| Change In Working Capital | -19.79M | 55.89M | -36.83M | -79.30M | 42.90M | |||
| Interest Paid | N/A | 25.38M | 37.86M | 34.90M | 18.70M | |||
| Taxes Paid | N/A | -114.00K | 118.00K | 0.00 | 1.20M | |||
| Other non cash items | -270.48M | -110.12M | 96.04M | 126.20M | 203.30M | |||
| OPERATING CASH FLOW | -105.87M | -20.44M | -174.88M | -241.10M | -37.40M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | -286.00K | -2.00M | -1.30M | |||
| Other Investing Activity | 445.05M | 230.32M | 144.93M | -164.80M | -137.10M | |||
| INVESTING CASH FLOW | 445.05M | 230.32M | 144.64M | -166.90M | -138.40M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -223.41M | 0.00 | 49.90M | -700.00K | |||
| Stock Issued/Repurchased | 429.00K | 2.67M | 74.22M | 9.40M | 54.30M | |||
| Other Financing Activity | -48.83M | 33.76M | -4.62M | -5.00M | -1.80M | |||
| FINANCING CASH FLOW | -281.72M | -186.97M | 69.60M | 54.30M | 51.90M | |||
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | |||
| CHANGE IN CASH | 57.46M | 22.91M | 39.36M | -353.70M | -123.90M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -105.87M | -20.44M | -174.88M | -241.10M | -37.40M | |||
| Capital Expenditure | N/A | N/A | -286.00K | -2.00M | -1.30M | |||
| FREE CASH FLOW | -105.87M | -20.44M | -175.17M | -243.10M | -38.70M | |||
All data in USD